Physician group Cellular Medicine Association stated on Monday that the US FDA has approved the use of the plasma (convalescent plasma) from the survivors of COVID-19 to be given as a life-saving treatment to those who may still be fighting to survive acute COVID-19 infection.
Cellular Medicine Association said people who survive COVID-19 harbor antibodies in their blood that fought the virus and won. Physicians struggle to quickly find the blood of a local person who has survived COVID-19 and who can donate the life-saving convalescent plasma, but the survivors do not know where to go to donate their blood.
The organisation has built a website, COVID19Switchboard.org, that connects those looking for blood and those wanting to give blood. This free switchboard works in every country (using Google Translate).
About 2000 company physicians and nurse practitioners in over 50 countries focus on connect potential donors with physicians through the procedures invented by Dr Runels--the Vampire Facelift, the Vampire Facial, the O-Shot and the Priapus Shot.
DATROWAY receives US priority review for first-line metastatic triple negative breast cancer
Lupin launches Dasatinib tablets in US market
Natera submits Signatera CDx PMA to FDA for bladder cancer use
Pharming receives FDA complete response letter for paediatric Joenja application
Trace Biosciences' IND application for nerve-specific imaging agent approved by FDA
Frontage expands early phase clinical research capabilities across US and China
MicuRx Pharmaceuticals' IND application for MRX-5 cleared by FDA
FDA approves Tenpoint Therapeutics' YUVEZZI as first dual-agent eye drop for presbyopia
Summit Therapeutics' BLA for ivonescimab in EGFR-mutated NSCLC accepted by FDA
WuXi Biologics collaborates with Sinorda Biomedicine for antibody development
Biogen's litifilimab receives FDA Breakthrough Therapy Designation for CLE
Glaukos receives FDA approval for repeat administration of iDose TR
Guerbet's contrast agent Elucirem approved by European Commission in children from birth
Spine Innovation's LOGIC Titanium Implant System receives US FDA 510(k) market approval